HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Gernot Seebacher Ernst Wolner Paul Simon Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rieder, E. Articles by Weigel, G. Search for Related Content PubMed PubMed Citation Articles by Rieder, E. Articles by Weigel, G. Related Collections Valve disease

J Thorac Cardiovasc Surg 2004;127:399-405
© 2004 The American Association for Thoracic Surgery

Surgery for acquired cardiovascular disease

Decellularization protocols of porcine heart valves differ importantly in efficiency of cell removal and susceptibility of the matrix to recellularization with human vascular cells

^a Department of Cardiothoracic Surgery and Ludwig-Boltzmann-Institute for Cardiosurgical Research, University of Vienna, Vienna, Austria

Received for publication March 22, 2003; revisions received May 1, 2003; accepted for publication June 23, 2003.

^* Address for reprints: Guenter Weigel, MD, Department of Cardiothoracic Surgery, University of Vienna, AKH, Waehringer Guertel 18-20, 1090 Vienna, Austria
guenter.weigel{at}akh-wien.ac.at

OBJECTIVE: We compared 3 different decellularization protocols in porcine heart valves for efficiency of complete cell removal and potential for recellularization.

METHODS: Porcine aortic and pulmonary roots were treated with trypsin, sodium-dodecyl-sulphate, or a new method using 0.25% tert-octylphenyl-polyoxyethylen in combination with sodium-deoxycholate. After a subsequent ribonuclease digestion, specimens were seeded with in vitro expanded human saphenous vein endothelial cells and myofibroblasts.

RESULTS: After treatment with trypsin and subsequent ribonuclease digestion, endothelial attachment took place; however, xenogenic cells were still visible within the matrix. Unexpectedly, when human cells were seeded onto specimens that had been decellularized with sodium-dodecyl-sulphate, the matrices were surrounded by nonviable endothelial cell fragments, indicating a toxic influence of the ionic detergent; 0.25% tert-octylphenyl-polyoxyethylen together with sodium-deoxycholate completely removed porcine cells and enabled host recellularization.

CONCLUSION: Compared with trypsin and sodium-dodecyl-sulphate involving decellularization procedures, reported to be effective in cell removal and susceptible to recellularization with human cells, only the porcine matrix treated with a new detergent-based decellularization method using 0.25% tert-octylphenyl-polyoxyethylen/sodium-deoxycholate followed by nuclease digestion presented an excellent scaffold for recellularization with human cells.

This article has been cited by other articles:

				A. Seguin, D. Radu, M. Holder-Espinasse, P. Bruneval, A. Fialaire-Legendre, M. Duterque-Coquillaud, A. Carpentier, and E. Martinod Tracheal Replacement With Cryopreserved, Decellularized, or Glutaraldehyde-Treated Aortic Allografts. Ann. Thorac. Surg., March 1, 2009; 87(3): 861 - 867. [Abstract] [Full Text] [PDF]

				P. M. Dohmen and W. Konertz Decellularization of Xenogenic Biologic Tissue Ann. Thorac. Surg., June 1, 2008; 85(6): 2163 - 2163. [Full Text] [PDF]

				D. Schmidt, U. A Stock, and S. P Hoerstrup Tissue engineering of heart valves using decellularized xenogeneic or polymeric starter matrices Phil Trans R Soc B, August 29, 2007; 362(1484): 1505 - 1512. [Abstract] [Full Text] [PDF]

				F. Juthier, A. Vincentelli, J. Gaudric, D. Corseaux, O. Fouquet, C. Calet, T. L. Tourneau, V. Soenen, C. Zawadzki, O. Fabre, et al. Decellularized heart valve as a scaffold for in vivo recellularization: Deleterious effects of granulocyte colony-stimulating factor J. Thorac. Cardiovasc. Surg., April 1, 2006; 131(4): 843 - 852. [Abstract] [Full Text] [PDF]

				T. Ota, Y. Sawa, S. Iwai, T. Kitajima, Y. Ueda, C. Coppin, H. Matsuda, and Y. Okita Fibronectin-Hepatocyte Growth Factor Enhances Reendothelialization in Tissue-Engineered Heart Valve Ann. Thorac. Surg., November 1, 2005; 80(5): 1794 - 1801. [Abstract] [Full Text] [PDF]

				I. Vesely Heart Valve Tissue Engineering Circ. Res., October 14, 2005; 97(8): 743 - 755. [Abstract] [Full Text] [PDF]

				A. Ketchedjian, A. L. Jones, P. Krueger, E. Robinson, K. Crouch, L. Wolfinbarger Jr, and R. Hopkins Recellularization of Decellularized Allograft Scaffolds in Ovine Great Vessel Reconstructions Ann. Thorac. Surg., March 1, 2005; 79(3): 888 - 896. [Abstract] [Full Text] [PDF]